ASH23
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
ASH23
Feb 23, 2024, 14:39 |
Insight
Manni Mohyuddin: Why striving for MRD negativity at all costs and having MRD as a primary endpoint may not be ideal
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Feb 3, 2024, 17:12 |
Positive
Naveen Pemmaraju: Thank you to Jane Fonda for helping us raise so much awareness for research on behalf of our patients with MPNs
Naveen Pemmaraju shared on X/Twitter: "It was amazing to spend a few quality moments with…
Jan 18, 2024, 10:38 |
Insight
Nicola Gökbuget: Time to acknowledge the very successful presentations of the German Multicenter Study Group for Adult ALL
Nicola Gökbuget, Head of Clinical Trial Center at Goethe University Hospital, posted on LinkedIn: "The…
Jan 11, 2024, 19:37 |
Blog
Join us for the upcoming post ASH23 Transplant/CT roundtable by The IACH - International Academy for Clinical Hematology
International Academy for Clinical Hematology made the following post on LinkedIn: "Join us for the…
Jan 1, 2024, 13:48 |
Career
Fumito Ito: I would like to congratulate Manali Begur on receiving an American Society of Hematology Abstract Achievement Award at ASH2023
Fumito Ito, Associate Professor of Surgery at University of Southern California, shared on LinkedIn: "I…
Dec 31, 2023, 12:04 |
Blog
Key updates in the treatment and management of myeloproliferative neoplasms - Video Journal of Hematology and Hematological Oncology
Quoting Video Journal of Hematology and Hematological Oncology on LinkedIn: "NEW MPN Session from ASH23.…
Dec 28, 2023, 18:21 |
Blog
Looking for a career where you can make a difference? - FDA Oncology
Quoting FDA Oncology on X/Twitter: "Looking for a career where you can make a difference?…
Dec 27, 2023, 13:52 |
Blog
Anas Younes: It is time to take a rest to recharge
Anas Younes posted on X/Twitter: "As we get closer to the end of the year,…
Dec 27, 2023, 13:13 |
Insight
Charles Gaulin: Safety of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma
Charles Gaulin, Lymphoma/Myeloma Fellow at MD Anderson Cancer Center, shared on LinkedIn: "At ASH23, we presented…
Dec 24, 2023, 18:13 |
Insight
Oncology Brothers: ASH23 Myeloma Highlights with Jens Hillengass:
Oncology Brothers shared on their X/Twitter page: "ASH23 Myeloma Highlights with Jens Hillengass. - PERSEUS…
1
2
3
4
5
All:
42
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube